Drug Type Synthetic peptide |
Synonyms |
Target |
Action agonists |
Mechanism VIPR agonists(Vasoactive intestinal peptide receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Myeloblastic Leukemia | Preclinical | United States | 10 Dec 2022 | |
Adult Acute Myeloblastic Leukemia | Preclinical | United States | 10 Dec 2022 |